Literature DB >> 7844676

Painful keratoderma and photophobia: hallmarks of tyrosinemia type II.

L G Rabinowitz1, L R Williams, C E Anderson, A Mazur, P Kaplan.   

Abstract

Tyrosinemia type II (Richner-Hanhart syndrome), which is caused by a deficiency of hepatic tyrosine aminotransferase, results in elevated plasma and urinary tyrosine concentrations. We describe a young boy who was seen at 6 months of age with red eyes, photophobia, and eye pain that were not suspected to be caused by tyrosinemia II until painful plantar keratoderma developed at 2 1/2 years of age. Treatment with a diet low in tyrosine and phenylalanine reversed the manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844676     DOI: 10.1016/s0022-3476(95)70558-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Richner Hanhart syndrome.

Authors:  Lalitha Janakiraman; Malathi Sathiyasekaran; Munirathiram Deenadayalan; Ramaswamy Ganesh; Uma Mahesh
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

2.  The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility.

Authors:  Gabriela K Ferreira; Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Leticia J Teixeira; Isabella T Mota; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-25       Impact factor: 3.584

3.  Tyrosine inhibits creatine kinase activity in cerebral cortex of young rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2011-07-26       Impact factor: 3.584

4.  An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain.

Authors:  Gabriela K Ferreira; Giselli Scaini; Isabela C Jeremias; Milena Carvalho-Silva; Cinara L Gonçalves; Talita C B Pereira; Giovanna M T Oliveira; Luiza W Kist; Maurício R Bogo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-04       Impact factor: 5.590

5.  Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.

Authors:  Gabriela K Ferreira; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Lislaine S Borges; Júlia S Vieira; Larissa S Constantino; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2012-07-31       Impact factor: 3.911

6.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

7.  Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S de Oliveira; Andréa P Rosa; Caroline Paula Mescka; Fernanda R Zanin; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-08-18       Impact factor: 3.584

8.  Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart syndrome).

Authors:  Jihad T Al-Ratrout; Mohammed Al-Muzian; Mona Al-Nazer; Naseem A Ansari
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

9.  The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients.

Authors:  Willem G van Ginkel; Hannah E van Reemst; Nienke S Kienstra; Anne Daly; Iris L Rodenburg; Anita MacDonald; Johannes G M Burgerhof; Pim de Blaauw; Jennifer van de Krogt; Saikat Santra; M Rebecca Heiner-Fokkema; Francjan J van Spronsen
Journal:  Nutrients       Date:  2019-11-18       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.